title: Nephrotic syndrome after treatment with pamidronate.
authors.affiliation: Department of Pathology, Columbia College of Physicians and Surgeons, New York, NY 10032, USA. vdd1@columbia.edu
authors.forename: Glen S
authors.initials: GS
authors.lastname: Markowitz
authors.forename: Paul L
authors.initials: PL
authors.lastname: Fine
authors.forename: Vivette D
authors.initials: VD
authors.lastname: D'agati
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D000077268:Pamidronate
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate